Valeant, a new business model and now, a new name
Share
Tweet
May 9, 2018
NEW YORK (AP) — Valeant Pharmaceuticals, which fell under withering scrutiny after acquiring the rights to drugs and then drastically raising their prices, is changing its name.
The Canadian company said Tuesday that it will be called Bausch Health Companies Inc. starting in July.
CEO Joseph Papa said in a prepared statement that the name change is "a major step forward" in the company's transformation.
Valeant Pharmaceuticals International Inc. fell into the crosshairs of Washington a couple years ago after an extended acquisition spree of other companies, followed by triple-digit price hikes...
For access to this article please
sign in or
subscribe.
Reader Comments(0)